#begin document (nw/p2.5_c2e/00/p2.5_c2e_0081); part 000
nw/p2.5_c2e/00/p2.5_c2e_0081   0    0      Xinhua     NNP  (TOP(FRAG(NP*   -   -   -   -   *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0    1        News     NNP              *   -   -   -   -   *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0    2      Agency     NNP              *)  -   -   -   -   *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0    3           ,       ,              *   -   -   -   -   *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0    4     Beijing     NNP           (NP*)  -   -   -   -   *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0    5           ,       ,              *   -   -   -   -   *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0    6    December     NNP           (NP*   -   -   -   -   *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0    7         19       CD              *)  -   -   -   -   *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0    8      -LRB-   -LRB-               *   -   -   -   -   *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0    9    Reporter      NN           (NP*   -   -   -   -   *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0   10          Li     NNP              *   -   -   -   -   *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0   11         Wen     NNP              *)  -   -   -   -   *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0   12      -RRB-   -RRB-              *))  -   -   -   -   *   -

nw/p2.5_c2e/00/p2.5_c2e_0081   0    0          More   JJR  (TOP(S(ADVP(NP(QP*           -    -   -   -   *      (ARGM-TMP*   (ARGM-TMP*   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0    1          than    IN                   *           -    -   -   -   *               *            *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0    2           60     CD                   *)          -    -   -   -   *               *            *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0    3         years   NNS                   *)          -    -   -   -   *               *            *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0    4           ago    RB                   *)          -    -   -   -   *               *)           *)  -
nw/p2.5_c2e/00/p2.5_c2e_0081   0    5             ,     ,                   *           -    -   -   -   *               *            *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0    6          when   WRB       (SBAR(WHADVP*)          -    -   -   -   *    (R-ARGM-TMP*)  (ARGM-TMP*   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0    7           the    DT           (S(NP(NP*           -    -   -   -   *          (ARG1*            *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0    8         world    NN                   *           -    -   -   -   *               *            *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0    9            's   POS                   *)          -    -   -   -   *               *            *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0   10         first    JJ                   *           -    -   -   -   *               *            *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0   11    penicillin    NN                   *           -    -   -   -   *               *            *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0   12    antibiotic    NN                   *)          -    -   -   -   *               *)           *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0   13           was   VBD                (VP*           -    -   -   -   *               *            *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0   14    introduced   VBN             (VP*))))   introduce  02   -   -   *             (V*)           *)  -
nw/p2.5_c2e/00/p2.5_c2e_0081   0   15             ,     ,                   *           -    -   -   -   *               *            *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0   16            it   PRP                (NP*)          -    -   -   -   *               *       (ARG1*)  -
nw/p2.5_c2e/00/p2.5_c2e_0081   0   17           was   VBD                (VP*           -    -   -   -   *               *            *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0   18     described   VBN                (VP*     describe  01   -   -   *               *          (V*)  -
nw/p2.5_c2e/00/p2.5_c2e_0081   0   19            as    IN                (PP*           -    -   -   -   *               *       (ARG2*   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0   20             "    ``                   *           -    -   -   -   *               *            *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0   21           the    DT             (NP(NP*           -    -   -   -   *               *            *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0   22         enemy    NN                   *)          -    -   -   -   *               *            *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0   23            of    IN                (PP*           -    -   -   -   *               *            *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0   24      bacteria   NNS           (NP*))))))          -    -   -   -   *               *            *)  -
nw/p2.5_c2e/00/p2.5_c2e_0081   0   25             .     .                   *           -    -   -   -   *               *            *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0   26             "    ''                  *))          -    -   -   -   *               *            *   -

nw/p2.5_c2e/00/p2.5_c2e_0081   0    0            But     CC           (TOP(S*            -    -   -   -   *         *    (ARGM-DIS*)            *             *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0    1            not     RB       (SBAR(ADVP*            -    -   -   -   *         *    (ARGM-TMP*             *             *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0    2           long     RB                 *)           -    -   -   -   *         *             *             *             *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0    3          after     IN                 *            -    -   -   -   *         *             *             *             *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0    4            men    NNS            (S(NP*)           -    -   -   -   *    (ARG1*)            *             *             *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0    5           were    VBD              (VP*            -    -   -   -   *         *             *             *             *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0    6    intoxicated    VBN              (VP*    intoxicate  01   1   -   *       (V*)            *             *             *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0    7             by     IN              (PP*            -    -   -   -   *    (ARG0*             *             *             *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0    8          their   PRP$           (NP(NP*            -    -   -   -   *         *             *             *             *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0    9        victory     NN                 *)           -    -   -   -   *         *             *             *             *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0   10           over     IN              (PP*            -    -   -   -   *         *             *             *             *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0   11         nature     NN       (NP*))))))))           -    -   -   -   *         *)            *)            *             *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0   12              ,      ,                 *            -    -   -   -   *         *             *             *             *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0   13           they    PRP              (NP*)           -    -   -   -   *         *        (ARG1*)            *             *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0   14           came    VBD              (VP*          come  04   3   -   *         *           (V*)            *             *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0   15             to     IN              (PP*            -    -   -   -   *         *        (ARG2*             *             *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0   16            the     DT              (NP*            -    -   -   -   *         *             *             *             *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0   17    realization     NN                 *            -    -   -   -   *         *             *             *             *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0   18           that     IN            (SBAR*            -    -   -   -   *         *             *             *             *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0   19              "     ``                 *            -    -   -   -   *         *             *             *             *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0   20           when    WRB   (S(SBAR(WHADVP*)           -    -   -   -   *         *             *    (ARGM-TMP*)   (ARGM-TMP*   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0   21            the     DT            (S(NP*            -    -   -   -   *         *             *        (ARG1*             *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0   22           good     JJ                 *)           -    -   -   -   *         *             *             *)            *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0   23       advances    VBZ              (VP*       advance  01   1   -   *         *             *           (V*)            *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0   24             by     IN              (PP*            -    -   -   -   *         *             *        (ARG2*             *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0   25            one     CD              (NP*            -    -   -   -   *         *             *             *             *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0   26           step     NN             *)))))           -    -   -   -   *         *             *             *)            *)  -
nw/p2.5_c2e/00/p2.5_c2e_0081   0   27              ,      ,                 *            -    -   -   -   *         *             *             *             *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0   28            its   PRP$              (NP*            -    -   -   -   *         *             *             *        (ARG1*   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0   29           evil     JJ                 *            -    -   -   -   *         *             *             *             *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0   30    counterpart     NN                 *)           -    -   -   -   *         *             *             *             *)  -
nw/p2.5_c2e/00/p2.5_c2e_0081   0   31           will     MD              (VP*            -    -   -   -   *         *             *             *    (ARGM-MOD*)  -
nw/p2.5_c2e/00/p2.5_c2e_0081   0   32        advance     VB              (VP*       advance  01   1   -   *         *             *             *           (V*)  -
nw/p2.5_c2e/00/p2.5_c2e_0081   0   33             by     IN              (PP*            -    -   -   -   *         *             *             *        (ARG2*   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0   34        several     JJ              (NP*            -    -   -   -   *         *             *             *             *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0   35          steps    NNS         *)))))))))           -    -   -   -   *         *             *)            *             *)  -
nw/p2.5_c2e/00/p2.5_c2e_0081   0   36              .      .                 *            -    -   -   -   *         *             *             *             *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0   37              "     ''                *))           -    -   -   -   *         *             *             *             *   -

nw/p2.5_c2e/00/p2.5_c2e_0081   0    0          The     DT  (TOP(S(NP(NP*         -    -   -   -   *        (ARG0*        *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0    1        speed     NN              *)        -    -   -   -   *             *        *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0    2           of     IN           (PP*         -    -   -   -   *             *        *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0    3          the     DT        (NP(NP*         -    -   -   -   *             *        *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0    4       growth     NN              *)        -    -   -   -   *             *        *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0    5           of     IN           (PP*         -    -   -   -   *             *        *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0    6         drug     NN      (NP(ADJP*         -    -   -   -   *             *        *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0    7           -    HYPH              *         -    -   -   -   *             *        *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0    8    resistant     JJ              *)        -    -   -   -   *             *        *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0    9     bacteria    NNS          *)))))        -    -   -   -   *             *)       *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0   10    obviously     RB         (ADVP*)        -    -   -   -   *    (ARGM-ADV*)       *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0   11     outpaces    VBZ           (VP*    outpace  01   -   -   *           (V*)       *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0   12          the     DT        (NP(NP*         -    -   -   -   *        (ARG1*        *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0   13        speed     NN              *)        -    -   -   -   *             *        *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0   14           of     IN           (PP*         -    -   -   -   *             *        *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0   15        human     JJ           (NP*         -    -   -   -   *             *        *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0   16       beings    NNS             *))        -    -   -   -   *             *        *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0   17           to     TO         (S(VP*         -    -   -   -   *             *        *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0   18      develop     VB           (VP*    develop  02   1   -   *             *      (V*)  -
nw/p2.5_c2e/00/p2.5_c2e_0081   0   19          new     JJ           (NP*         -    -   -   -   *             *   (ARG1*   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0   20        drugs    NNS         *))))))        -    -   -   -   *             *)       *)  -
nw/p2.5_c2e/00/p2.5_c2e_0081   0   21            .      .             *))        -    -   -   -   *             *        *   -

nw/p2.5_c2e/00/p2.5_c2e_0081   0    0           World    NNP    (TOP(S(NP(NML*       -    -   -   -   *        (ARG1*             *               *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0    1          Health    NNP                 *       -    -   -   -   *             *             *               *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0    2    Organization    NNP                 *)      -    -   -   -   *             *             *               *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0    3         experts    NNS                 *)      -    -   -   -   *             *)            *               *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0    4             are    VBP              (VP*       be  01   1   -   *           (V*)            *               *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0    5             now     RB            (ADVP*)      -    -   -   -   *    (ARGM-TMP*)            *               *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0    6            even     RB            (ADJP*       -    -   -   -   *        (ARG2*             *               *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0    7         worried     JJ                 *       -    -   -   -   *             *             *               *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0    8            that     IN            (SBAR*       -    -   -   -   *             *             *               *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0    9               "     ``                 *       -    -   -   -   *             *             *               *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0   10               a     DT            (S(NP*       -    -   -   -   *             *        (ARG0*               *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0   11           super     JJ                 *       -    -   -   -   *             *             *               *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0   12             all     DT        (ADJP(NML*       -    -   -   -   *             *             *               *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0   13              -    HYPH                 *       -    -   -   -   *             *             *               *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0   14            drug     NN                 *)      -    -   -   -   *             *             *               *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0   15              -    HYPH                 *       -    -   -   -   *             *             *               *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0   16       resistant     JJ                 *)      -    -   -   -   *             *             *               *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0   17             new     JJ                 *       -    -   -   -   *             *             *               *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0   18        bacteria    NNS                 *)      -    -   -   -   *             *             *)              *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0   19            will     MD              (VP*       -    -   -   -   *             *    (ARGM-MOD*)              *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0   20           bring     VB              (VP*    bring  01   1   -   *             *           (V*)              *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0   21           human     JJ              (NP*       -    -   -   -   *             *        (ARG1*               *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0   22          beings    NNS                 *)      -    -   -   -   *             *             *)              *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0   23            back     RB            (ADVP*       -    -   -   -   *             *        (ARG2*               *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0   24              to     IN              (PP*       -    -   -   -   *             *             *               *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0   25              an     DT           (NP(NP*       -    -   -   -   *             *             *      (ARGM-TMP*   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0   26             era     NN                 *)      -    -   -   -   *             *             *               *)  -
nw/p2.5_c2e/00/p2.5_c2e_0081   0   27            when    WRB     (SBAR(WHADVP*)      -    -   -   -   *             *             *    (R-ARGM-TMP*)  -
nw/p2.5_c2e/00/p2.5_c2e_0081   0   28      infectious     JJ            (S(NP*       -    -   -   -   *             *             *          (ARG0*   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0   29         disease     NN                 *)      -    -   -   -   *             *             *               *)  -
nw/p2.5_c2e/00/p2.5_c2e_0081   0   30           raged    VBD   (VP*))))))))))))    rage  02   1   -   *             *)            *)            (V*)  -
nw/p2.5_c2e/00/p2.5_c2e_0081   0   31               .      .                 *       -    -   -   -   *             *             *               *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0   32               "     ''                *))      -    -   -   -   *             *             *               *   -

nw/p2.5_c2e/00/p2.5_c2e_0081   0    0            The    DT   (TOP(S(NP(NP*       -    -   -   -   *   (ARG1*             *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0    1          birth    NN               *)      -    -   -   -   *        *             *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0    2             of    IN            (PP*       -    -   -   -   *        *             *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0    3          super    JJ            (NP*       -    -   -   -   *        *             *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0    4       bacteria   NNS             *)))      -    -   -   -   *        *)            *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0    5             is   VBZ            (VP*       -    -   -   -   *        *             *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0    6         caused   VBN            (VP*    cause  01   -   -   *      (V*)            *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0    7             by    IN            (PP*       -    -   -   -   *   (ARG0*             *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0    8            man    NN      (NP(NP(NP*       -    -   -   -   *        *             *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0    9             's   POS               *)      -    -   -   -   *        *             *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0   10      excessive    JJ               *       -    -   -   -   *        *             *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0   11            use    NN               *)      -    -   -   -   *        *             *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0   12             of    IN            (PP*       -    -   -   -   *        *             *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0   13    antibiotics   NNS           (NP*))      -    -   -   -   *        *             *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0   14           when   WRB   (SBAR(WHADVP*)      -    -   -   -   *        *    (ARGM-TMP*)  -
nw/p2.5_c2e/00/p2.5_c2e_0081   0   15           they   PRP          (S(NP*)      -    -   -   -   *        *        (ARG1*)  -
nw/p2.5_c2e/00/p2.5_c2e_0081   0   16            are   VBP            (VP*       be  01   1   -   *        *           (V*)  -
nw/p2.5_c2e/00/p2.5_c2e_0081   0   17           sick    JJ   (ADJP*))))))))      -    -   -   -   *        *)       (ARG2*)  -
nw/p2.5_c2e/00/p2.5_c2e_0081   0   18              .     .              *))      -    -   -   -   *        *             *   -

nw/p2.5_c2e/00/p2.5_c2e_0081   0    0          There    EX   (TOP(S(S(NP*)           -    -   -   -   *        *             *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0    1            are   VBP           (VP*            be  02   3   -   *      (V*)            *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0    2            two    CD        (NP(NP*            -    -   -   -   *   (ARG1*             *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0    3        dangers   NNS              *)           -    -   -   -   *        *             *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0    4             in    IN           (PP*            -    -   -   -   *        *             *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0    5            the    DT        (NP(NP*            -    -   -   -   *        *             *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0    6      excessive    JJ              *            -    -   -   -   *        *             *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0    7            use    NN              *)           -    -   -   -   *        *             *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0    8             of    IN           (PP*            -    -   -   -   *        *             *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0    9    antibiotics   NNS     (NP*)))))))           -    -   -   -   *        *)            *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0   10              :     :              *            -    -   -   -   *        *             *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0   11          first    RB       (S(ADVP*)           -    -   -   -   *        *    (ARGM-TMP*)  -
nw/p2.5_c2e/00/p2.5_c2e_0081   0   12              ,     ,              *            -    -   -   -   *        *             *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0   13             it   PRP           (NP*)           -    -   -   -   *        *        (ARG0*)  -
nw/p2.5_c2e/00/p2.5_c2e_0081   0   14              "    ``              *            -    -   -   -   *        *             *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0   15    strengthens   VBZ           (VP*    strengthen  01   1   -   *        *           (V*)  -
nw/p2.5_c2e/00/p2.5_c2e_0081   0   16            the    DT           (NP*            -    -   -   -   *        *        (ARG1*   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0   17          enemy    NN              *            -    -   -   -   *        *             *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0   18          group    NN            *)))           -    -   -   -   *        *             *)  -
nw/p2.5_c2e/00/p2.5_c2e_0081   0   19              .     .              *            -    -   -   -   *        *             *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0   20              "    ''             *))           -    -   -   -   *        *             *   -

nw/p2.5_c2e/00/p2.5_c2e_0081   0    0      Currently     RB   (TOP(S(ADVP*)          -    -   -   -   *    (ARGM-TMP*)  -
nw/p2.5_c2e/00/p2.5_c2e_0081   0    1              ,      ,              *           -    -   -   -   *             *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0    2    antibiotics    NNS           (NP*)          -    -   -   -   *        (ARG0*)  -
nw/p2.5_c2e/00/p2.5_c2e_0081   0    3            can     MD           (VP*           -    -   -   -   *    (ARGM-MOD*)  -
nw/p2.5_c2e/00/p2.5_c2e_0081   0    4            not     RB              *           -    -   -   -   *    (ARGM-NEG*)  -
nw/p2.5_c2e/00/p2.5_c2e_0081   0    5      eliminate     VB           (VP*    eliminate  01   1   -   *           (V*)  -
nw/p2.5_c2e/00/p2.5_c2e_0081   0    6           some     DT           (NP*           -    -   -   -   *        (ARG1*   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0    7              "     ``              *           -    -   -   -   *             *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0    8            new     JJ          (NML*           -    -   -   -   *             *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0    9     generation     NN              *)          -    -   -   -   *             *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0   10              "     ''              *           -    -   -   -   *             *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0   11           drug     NN         (ADJP*           -    -   -   -   *             *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0   12             -    HYPH              *           -    -   -   -   *             *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0   13      resistant     JJ              *)          -    -   -   -   *             *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0   14       bacteria    NNS            *)))          -    -   -   -   *             *)  -
nw/p2.5_c2e/00/p2.5_c2e_0081   0   15              .      .             *))          -    -   -   -   *             *   -

nw/p2.5_c2e/00/p2.5_c2e_0081   0    0             In    IN    (TOP(S(S(PP*        -    -   -   -   *             *   (ARGM-TMP*             *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0    1          1928     CD           (NP*))       -    -   -   -   *             *            *)            *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0    2              ,     ,               *        -    -   -   -   *             *            *             *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0    3           when   WRB   (SBAR(WHADVP*)       -    -   -   -   *    (ARGM-TMP*)  (ARGM-TMP*             *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0    4            the    DT    (S(NP(NP(NP*        -    -   -   -   *        (ARG1*            *             *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0    5     forefather    NN               *)       -    -   -   -   *             *            *             *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0    6             of    IN            (PP*        -    -   -   -   *             *            *             *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0    7    antibiotics   NNS          (NP*)))       -    -   -   -   *             *            *             *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0    8             -      :               *        -    -   -   -   *             *            *             *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0    9     penicillin    NN            (NP*)       -    -   -   -   *             *            *             *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0   10             -      :               *)       -    -   -   -   *             *)           *             *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0   11            was   VBD            (VP*        -    -   -   -   *             *            *             *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0   12       launched   VBN         (VP*))))   launch  01   -   -   *           (V*)           *)            *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0   13              ,     ,               *        -    -   -   -   *             *            *             *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0   14             it   PRP            (NP*)       -    -   -   -   *      (R-ARG1*)           *             *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0   15         seemed   VBD            (VP*      seem  01   1   -   *             *          (V*)            *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0   16     invincible    JJ     (S(ADJP*))))       -    -   -   -   *             *       (ARG1*)            *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0   17              ,     ,               *        -    -   -   -   *             *            *             *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0   18            but    CC               *        -    -   -   -   *             *            *             *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0   19            now    RB        (S(ADVP*)       -    -   -   -   *             *            *    (ARGM-TMP*)  -
nw/p2.5_c2e/00/p2.5_c2e_0081   0   20              ,     ,               *        -    -   -   -   *             *            *             *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0   21             it   PRP            (NP*)       -    -   -   -   *             *            *        (ARG1*)  -
nw/p2.5_c2e/00/p2.5_c2e_0081   0   22             is   VBZ            (VP*        -    -   -   -   *             *            *             *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0   23        getting   VBG            (VP*       get  03   3   -   *             *            *           (V*)  -
nw/p2.5_c2e/00/p2.5_c2e_0081   0   24            old    JJ          (ADJP*        -    -   -   -   *             *            *        (ARG2*   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0   25            and    CC               *        -    -   -   -   *             *            *             *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0   26           weak    JJ            *))))       -    -   -   -   *             *            *             *)  -
nw/p2.5_c2e/00/p2.5_c2e_0081   0   27              .     .              *))       -    -   -   -   *             *            *             *   -

nw/p2.5_c2e/00/p2.5_c2e_0081   0    0               Now    RB   (TOP(S(ADVP*)          -    -   -   -   *    (ARGM-TMP*)  -
nw/p2.5_c2e/00/p2.5_c2e_0081   0    1                 ,     ,              *           -    -   -   -   *             *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0    2              even    RB        (NP(NP*           -    -   -   -   *        (ARG1*   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0    3               the    DT              *           -    -   -   -   *             *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0    4               top    JJ              *           -    -   -   -   *             *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0    5        antibiotic    JJ              *           -    -   -   -   *             *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0    6             brand    NN              *)          -    -   -   -   *             *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0    7        vancomycin   NNP          (NP*))          -    -   -   -   *             *)  -
nw/p2.5_c2e/00/p2.5_c2e_0081   0    8                is   VBZ           (VP*           -    -   -   -   *             *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0    9              also    RB         (ADVP*)          -    -   -   -   *    (ARGM-ADV*)  -
nw/p2.5_c2e/00/p2.5_c2e_0081   0   10        challenged   VBN           (VP*    challenge  01   1   -   *           (V*)  -
nw/p2.5_c2e/00/p2.5_c2e_0081   0   11                by    IN           (PP*           -    -   -   -   *        (ARG0*   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0   12               the    DT           (NP*           -    -   -   -   *             *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0   13               new    JJ          (NML*           -    -   -   -   *             *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0   14        generation    NN              *)          -    -   -   -   *             *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0   15    Staphylococcus   NNP              *           -    -   -   -   *             *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0   16            aureus   NNP           *))))          -    -   -   -   *             *)  -
nw/p2.5_c2e/00/p2.5_c2e_0081   0   17                 .     .             *))          -    -   -   -   *             *   -

nw/p2.5_c2e/00/p2.5_c2e_0081   0    0        Right    RB  (TOP(S(ADVP*       -    -    -   -   *            *        *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0    1          now    RB             *)      -    -    -   -   *            *        *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0    2            ,     ,             *       -    -    -   -   *            *        *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0    3          the    DT          (NP*       -    -    -   -   *       (ARG0*        *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0    4       United   NNP             *       -    -    -   -   *            *        *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0    5       States   NNP             *)      -    -    -   -   *            *)       *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0    6          has   VBZ          (VP*     have   -   12   -   *            *        *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0    7           to    TO        (S(VP*       -    -    -   -   *            *        *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0    8        spend    VB          (VP*    spend  01    2   -   *          (V*)       *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0    9          two    CD       (NP(QP*       -    -    -   -   *       (ARG3*        *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0   10           to    TO             *       -    -    -   -   *            *        *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0   11         four    CD             *       -    -    -   -   *            *        *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0   12      billion    CD             *)      -    -    -   -   *            *        *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0   13         U.S.   NNS             *       -    -    -   -   *            *        *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0   14      Dollars   NNS             *)      -    -    -   -   *            *)       *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0   15         each    DT          (NP*       -    -    -   -   *   (ARGM-TMP*        *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0   16         year    NN          *))))      -    -    -   -   *            *)       *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0   17           to    TO        (S(VP*       -    -    -   -   *            *        *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0   18        fight    VB          (VP*    fight  01    1   -   *            *      (V*)  -
nw/p2.5_c2e/00/p2.5_c2e_0081   0   19          the    DT          (NP*       -    -    -   -   *            *   (ARG1*   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0   20    anti-drug    JJ             *       -    -    -   -   *            *        *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0   21     bacteria   NNS         *)))))      -    -    -   -   *            *        *)  -
nw/p2.5_c2e/00/p2.5_c2e_0081   0   22            .     .            *))      -    -    -   -   *            *        *   -

nw/p2.5_c2e/00/p2.5_c2e_0081   0    0            And    CC        (TOP(S*      -    -   -   -   *         *    (ARGM-DIS*)          *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0    1           what    WP    (SBAR(WHNP*)     -    -   -   -   *    (ARG1*)       (ARG1*           *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0    2             is   VBZ         (S(VP*      be  01   1   -   *       (V*)            *           *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0    3           most   RBS         (ADJP*      -    -   -   -   *    (ARG2*             *           *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0    4       shocking    JJ           *))))     -    -   -   -   *         *)            *)          *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0    5             is   VBZ           (VP*      be  01   1   -   *         *           (V*)          *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0    6            the    DT        (NP(NP*      -    -   -   -   *         *        (ARG2*           *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0    7          birth    NN              *)     -    -   -   -   *         *             *           *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0    8             of    IN           (PP*      -    -   -   -   *         *             *           *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0    9              "    ``           (NP*      -    -   -   -   *         *             *           *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0   10          super    JJ           (NP*      -    -   -   -   *         *             *      (ARG2*   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0   11       bacteria   NNS              *)     -    -   -   -   *         *             *           *)  -
nw/p2.5_c2e/00/p2.5_c2e_0081   0   12              "    ''              *      -    -   -   -   *         *             *           *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0   13           that   WDT    (SBAR(WHNP*)     -    -   -   -   *         *             *    (R-ARG2*)  -
nw/p2.5_c2e/00/p2.5_c2e_0081   0   14           feed   VBP         (S(VP*    feed  01   5   -   *         *             *         (V*)  -
nw/p2.5_c2e/00/p2.5_c2e_0081   0   15             on    IN           (PP*      -    -   -   -   *         *             *      (ARG1*   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0   16    antibiotics   NNS   (NP*)))))))))     -    -   -   -   *         *             *)          *)  -
nw/p2.5_c2e/00/p2.5_c2e_0081   0   17              .     .             *))     -    -   -   -   *         *             *           *   -

nw/p2.5_c2e/00/p2.5_c2e_0081   0   0      Secondly    RB   (TOP(S(ADVP*)          -    -   -   -   *    (ARGM-DIS*)  -
nw/p2.5_c2e/00/p2.5_c2e_0081   0   1             ,     ,              *           -    -   -   -   *             *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0   2            it   PRP           (NP*)          -    -   -   -   *        (ARG0*)  -
nw/p2.5_c2e/00/p2.5_c2e_0081   0   3             "    ``              *           -    -   -   -   *             *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0   4    undermines   VBZ           (VP*    undermine  01   -   -   *           (V*)  -
nw/p2.5_c2e/00/p2.5_c2e_0081   0   5           the    DT           (NP*           -    -   -   -   *        (ARG1*   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0   6        united    JJ              *           -    -   -   -   *             *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0   7         front    NN             *))          -    -   -   -   *             *)  -
nw/p2.5_c2e/00/p2.5_c2e_0081   0   8             .     .              *           -    -   -   -   *             *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0   9             "    ''             *))          -    -   -   -   *             *   -

nw/p2.5_c2e/00/p2.5_c2e_0081   0    0          There    EX   (TOP(S(S(NP*)      -    -   -   -   *        *            *             *        *             *        *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0    1            are   VBP           (VP*       be  02   3   -   *      (V*)           *             *        *             *        *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0    2           many    JJ        (NP(NP*       -    -   -   -   *   (ARG1*       (ARG0*             *        *             *        *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0    3        healthy    JJ              *       -    -   -   -   *        *            *             *        *             *        *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0    4       bacteria   NNS              *)      -    -   -   -   *        *            *)            *        *             *        *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0    5         living   VBG           (VP*     live  01   2   -   *        *          (V*)            *        *             *        *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0    6             in    IN           (PP*       -    -   -   -   *        *   (ARGM-LOC*             *        *             *        *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0    7            the    DT           (NP*       -    -   -   -   *        *            *             *        *             *        *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0    8          human    JJ              *       -    -   -   -   *        *            *             *        *             *        *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0    9           body    NN         *))))))      -    -   -   -   *        *)           *)            *        *             *        *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0   10              ,     ,              *       -    -   -   -   *        *            *             *        *             *        *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0   11            but    CC              *       -    -   -   -   *        *            *             *        *             *        *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0   12            the    DT      (S(NP(NP*       -    -   -   -   *        *            *        (ARG0*        *             *        *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0   13      excessive    JJ              *       -    -   -   -   *        *            *             *        *             *        *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0   14            use    NN              *)      -    -   -   -   *        *            *             *        *             *        *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0   15             of    IN           (PP*       -    -   -   -   *        *            *             *        *             *        *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0   16    antibiotics   NNS         (NP*)))      -    -   -   -   *        *            *             *)       *             *        *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0   17           will    MD           (VP*       -    -   -   -   *        *            *    (ARGM-MOD*)       *             *        *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0   18           kill    VB           (VP*     kill  01   3   -   *        *            *           (V*)       *             *        *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0   19          these    DT           (NP*       -    -   -   -   *        *            *        (ARG1*        *             *        *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0   20              "    ``              *       -    -   -   -   *        *            *             *        *             *        *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0   21         allies   NNS              *)      -    -   -   -   *        *            *             *)       *             *        *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0   22              ,     ,              *       -    -   -   -   *        *            *             *        *             *        *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0   23              "    ''              *       -    -   -   -   *        *            *             *        *             *        *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0   24        leading   VBG      (S(VP(VP*     lead  03   1   -   *        *            *    (ARGM-ADV*      (V*)            *        *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0   25             to    IN           (PP*       -    -   -   -   *        *            *             *   (ARG2*             *        *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0   26              a    DT        (NP(NP*       -    -   -   -   *        *            *             *        *             *        *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0   27           loss    NN              *)      -    -   -   -   *        *            *             *        *             *        *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0   28             of    IN           (PP*       -    -   -   -   *        *            *             *        *             *        *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0   29      alignment    NN          (NP*))      -    -   -   -   *        *            *             *        *             *        *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0   30          among    IN           (PP*       -    -   -   -   *        *            *             *        *             *        *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0   31            the    DT           (NP*       -    -   -   -   *        *            *             *        *             *        *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0   32       bacteria   NNS              *       -    -   -   -   *        *            *             *        *             *        *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0   33         groups   NNS          *)))))      -    -   -   -   *        *            *             *        *)            *        *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0   34              ,     ,              *       -    -   -   -   *        *            *             *        *             *        *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0   35            and    CC              *       -    -   -   -   *        *            *             *        *             *        *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0   36          hence    RB         (ADVP*)      -    -   -   -   *        *            *             *        *    (ARGM-DIS*)       *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0   37       allowing   VBG           (VP*    allow  01   1   -   *        *            *             *        *           (V*)       *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0   38      anti-drug    JJ         (S(NP*       -    -   -   -   *        *            *             *        *        (ARG1*   (ARG0*   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0   39       bacteria   NNS              *)      -    -   -   -   *        *            *             *        *             *        *)  -
nw/p2.5_c2e/00/p2.5_c2e_0081   0   40             to    TO           (VP*       -    -   -   -   *        *            *             *        *             *        *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0   41            get    VB           (VP*      get  01   1   -   *        *            *             *        *             *      (V*)  -
nw/p2.5_c2e/00/p2.5_c2e_0081   0   42              a    DT           (NP*       -    -   -   -   *        *            *             *        *             *   (ARG1*   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0   43         chance    NN     *))))))))))      -    -   -   -   *        *            *             *)       *             *)       *)  -
nw/p2.5_c2e/00/p2.5_c2e_0081   0   44              .     .             *))      -    -   -   -   *        *            *             *        *             *        *   -

nw/p2.5_c2e/00/p2.5_c2e_0081   0    0                Some    DT   (TOP(S(NP(NP*)      -    -   -   -   *        (ARG0*             *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0    1                  of    IN            (PP*       -    -   -   -   *             *             *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0    2                them   PRP          (NP*)))      -    -   -   -   *             *)            *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0    3                 may    MD            (VP*       -    -   -   -   *    (ARGM-MOD*)            *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0    4               cause    VB            (VP*    cause  01   -   -   *           (V*)            *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0    5    pseudomembranous    JJ         (NP(NP*       -    -   -   -   *        (ARG1*             *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0    6             colitis    NN               *)      -    -   -   -   *             *             *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0    7                   ,     ,               *       -    -   -   -   *             *             *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0    8               which   WDT     (SBAR(WHNP*)      -    -   -   -   *             *             *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0    9                 has   VBZ          (S(VP*     have   -   2   -   *             *             *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0   10                   a    DT         (NP(NP*       -    -   -   -   *             *             *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0   11               death    NN               *       -    -   -   -   *             *             *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0   12                rate    NN               *)      -    -   -   -   *             *             *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0   13                  as    RB     (ADJP(ADJP*       -    -   -   -   *             *             *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0   14                high    JJ               *)      -    -   -   -   *             *             *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0   15                  as    IN            (PP*       -    -   -   -   *             *             *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0   16                 20     CD            (NP*       -    -   -   -   *             *             *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0   17                   %    NN            *))))      -    -   -   -   *             *             *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0   18                   ,     ,               *       -    -   -   -   *             *             *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0   19               while    IN          (SBAR*       -    -   -   -   *             *             *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0   20              others   NNS          (S(NP*)      -    -   -   -   *             *        (ARG0*)  -
nw/p2.5_c2e/00/p2.5_c2e_0081   0   21                 may    MD            (VP*       -    -   -   -   *             *    (ARGM-MOD*)  -
nw/p2.5_c2e/00/p2.5_c2e_0081   0   22                lead    VB            (VP*     lead  03   1   -   *             *           (V*)  -
nw/p2.5_c2e/00/p2.5_c2e_0081   0   23                  to    IN            (PP*       -    -   -   -   *             *        (ARG2*   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0   24           dangerous    JJ            (NP*       -    -   -   -   *             *             *   -
nw/p2.5_c2e/00/p2.5_c2e_0081   0   25          septicemia    NN    *))))))))))))      -    -   -   -   *             *)            *)  -
nw/p2.5_c2e/00/p2.5_c2e_0081   0   26                   .     .              *))      -    -   -   -   *             *             *   -

#end document
